University of Glasgow Study Demonstrates the Ability of Oxycyte® to Supply Oxygen to Critical Penumbral Tissue in Acute Ischemic Stroke
07:00 EDT 21 Aug 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
Oxygen Biotherapeutics, Inc. (“OBI”) (NASDAQ: OXBT) announced today that
recent research conducted by its partner, Aurum Biosciences (“Aurum”),
Glasgow, Scotland, has shown that Oxycyte®, OBI’s proprietary
perfluoroca...
Other Sources for this Article
Oxygen Biotherapeutics, Inc.
Ellen Corliss, 919-855-2112
Senior
Vice President
Corporate Communications
& Investor Relations
More From BioPortfolio on "University of Glasgow Study Demonstrates the Ability of Oxycyte® to Supply Oxygen to Critical Penumbral Tissue in Acute Ischemic Stroke"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
